---
name: WuXi Vaccines
slug: wuxivaccines
site: cdmo
website_domain: wuxivaccines.com
summary: Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered. Headquartered in Suzhou, China.
tagline: End-to-end vaccine and prophylactic antibody CDMO with global GMP-certified facilities.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: WuXi Biologics
parent_slug: wuxibiologics
hq_country: CN
tier2_domain_verified: false
updated_at: 2026-09-27T07:00:56.094Z
services_count: 11
modalities_count: 4
indications_count: 1
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# WuXi Vaccines

End-to-end vaccine and prophylactic antibody CDMO with global GMP-certified facilities.

Listed on cdmo.directory.

## Summary

Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered. Headquartered in Suzhou, China.

## At a glance

- Parent: [WuXi Biologics](/companies/wuxibiologics)
- HQ country: CN

## Services

- Vaccine Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Formulation Development
- Process Development
- CMC Analytical Development
- Quality Control Testing
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Biologics Development & Manufacturing

## Modalities

- Vaccine
- mRNA
- Biologics (Monoclonal Antibodies)
- Biologics (Other)

## Indications

- Infectious Disease

## Locations

- Headquarters, Suzhou, Jiangsu, China

## Long description

WuXi Vaccines is a subsidiary of WuXi Biologics focused on contract development and manufacturing of vaccine and prophylactic antibody products. The organization provides integrated, end-to-end solutions spanning cell line development, upstream and downstream process development, final drug product formulation, GMP manufacturing, and analytical testing.

**Modalities & Platforms:**
- **Mammalian:** monoclonal antibodies (mAb), recombinant proteins (rProtein), nanoparticles, and virus-like particles (VLP)
- **Viral:** live-attenuated and viral-vectored vaccine platforms
- **Microbial:** recombinant proteins, VLP, and outer membrane vesicles (OMV)
- **Nucleic Acid:** mRNA and plasmid DNA (pDNA) technologies

**Regulatory & Quality:**
WuXi Vaccines operates multiple globally GMP-certified facilities with 7 regulatory inspections passed and 5 facilities certified as of June 2026. The organization has delivered over 550 million doses to more than 180 countries and manages over 107 projects in development.

**Service Scope:**
Full development and manufacturing capabilities from discovery through late-stage development and commercialization, with dedicated analytical testing services. The company emphasizes CMC and regulatory expertise, quality assurance, and IP protection as core differentiators.

## Related companies

- [Bionova Scientific](/companies/bionova-scientific) (Cell-Line Development, Upstream Processing) — [Compare](/compare/bionova-scientific/wuxivaccines)
- [KBI Biopharma, Inc.](/companies/kbibiopharma) (Cell-Line Development, Upstream Processing) — [Compare](/compare/kbibiopharma/wuxivaccines)
- [Cytovance Biologics](/companies/cytovance-biologics) (Vaccine Manufacturing, Cell-Line Development) — [Compare](/compare/cytovance-biologics/wuxivaccines)
- [Creative Biolabs](/companies/creativebiolabs) (Cell-Line Development, Process Development) — [Compare](/compare/creativebiolabs/wuxivaccines)
- [Avid Bioservices](/companies/avidbio) (Cell-Line Development, Upstream Processing) — [Compare](/compare/avidbio/wuxivaccines)
- [FUJIFILM Biotechnologies](/companies/fujifilm-biotechnologies) (Vaccine Manufacturing, Cell-Line Development) — [Compare](/compare/fujifilm-biotechnologies/wuxivaccines)
- [WuXi Biologics](/companies/wuxibiologics) (Cell-Line Development, Upstream Processing) — [Compare](/compare/wuxibiologics/wuxivaccines)
- [Celonic](/companies/celonic) (Cell-Line Development, Upstream Processing) — [Compare](/compare/celonic/wuxivaccines)

_Profile last updated: 2026-09-27T07:00:56.094Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.